Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole
- PMID: 17883958
- DOI: 10.1111/j.1745-7254.2007.00617.x
Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole
Abstract
Aim: To explore the potential interactions between yin zhi huang (YZH) and omeprazole, a substrate of CYP3A4 and CYP2C19.
Methods: Eighteen healthy volunteers, including 6 CYP2C19*1/*1, 6 CYP2C19*1/*2 or *3 and 6 CYP2C19*2/*2 were enrolled in a 2-phase, randomized, crossover clinical trial. In each phase, the volunteers received either placebo or 10 mL YZH oral liquid, 3 times daily for 14 d. Then all the patients took a 20 mg omeprazole capsule orally. Blood samples were collected up to 12 h after omeprazole administration. Plasma concentrations of omeprazole and its metabolites were quantified by HPLC with UV detection.
Results: After 14 d of treatment of YZH, plasma omeprazole significantly decreased and those of omeprazole sulfone and 5-hydroxyomeprazole significantly increased. The ratios of the area under the plasma concentration-time curves from time 0 to infinity (AUC(0-infinity) of omeprazole to 5-hydroxyomprazole and those of omeprazole to omeprazole sulfone decreased by 64.80%+/-12.51% (P=0.001) and 63.31%+/-18.45% (P=0.004) in CYP2C19*1/*1, 57.98%+/-14.80% (P=0.002) and 54.87%+/-18.42% (P=0.003) in CYP2C19*1/*2 or *3, and 37.74%+/-16.07% (P=0.004) and 45.16%+/-15.54% (P=0.003) in CYP2C19*2/*2, respectively. The decrease of the AUC(0-infinity) ratio of omeprazole to 5-hydroxyomprazole in CYP2C19*1/*1 and CYP2C19*1/*2 or *3 was greater than those in CYP2C19*2/*2 (P=0.047 and P=0.009).
Conclusion: YZH induces both CYP3A4-catalyzed sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole leading to decreases in plasma omeprazole concentrations.
Similar articles
-
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.Clin Pharmacol Ther. 2004 Mar;75(3):191-7. doi: 10.1016/j.clpt.2003.09.014. Clin Pharmacol Ther. 2004. PMID: 15001970 Clinical Trial.
-
Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.J Clin Pharmacol. 2009 May;49(5):574-81. doi: 10.1177/0091270009333016. J Clin Pharmacol. 2009. PMID: 19398604 Clinical Trial.
-
Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes.Xenobiotica. 2010 Jun;40(6):393-9. doi: 10.3109/00498251003748095. Xenobiotica. 2010. PMID: 20350051 Clinical Trial.
-
Comparative pharmacokinetics of Omeprazole and its metabolites in poor and extensive metabolizer Pakistani healthy volunteers and a review of different studies.Pak J Pharm Sci. 2018 Jul;31(4):1363-1374. Pak J Pharm Sci. 2018. PMID: 30033421 Review.
-
Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.Clin Pharmacokinet. 2001;40(7):523-37. doi: 10.2165/00003088-200140070-00004. Clin Pharmacokinet. 2001. PMID: 11510629 Review.
Cited by
-
In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong.Evid Based Complement Alternat Med. 2012;2012:430262. doi: 10.1155/2012/430262. Epub 2012 Feb 16. Evid Based Complement Alternat Med. 2012. PMID: 22454664 Free PMC article.
-
Herb-Drug Interactions: Worlds Intersect with the Patient at the Center.Medicines (Basel). 2021 Aug 5;8(8):44. doi: 10.3390/medicines8080044. Medicines (Basel). 2021. PMID: 34436223 Free PMC article. Review.
-
Pharmacogenomics and herb-drug interactions: merge of future and tradition.Evid Based Complement Alternat Med. 2015;2015:321091. doi: 10.1155/2015/321091. Epub 2015 Mar 2. Evid Based Complement Alternat Med. 2015. PMID: 25821484 Free PMC article. Review.
-
A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism.Chin J Integr Med. 2014 Dec;20(12):894-902. doi: 10.1007/s11655-014-2023-z. Epub 2014 Nov 27. Chin J Integr Med. 2014. PMID: 25428337 Clinical Trial.
-
Interactions between clopidogrel and traditional Chinese medicine.J Thromb Thrombolysis. 2019 Oct;48(3):491-499. doi: 10.1007/s11239-019-01945-3. J Thromb Thrombolysis. 2019. PMID: 31471773 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources